Fluorine in PDB 8pbo: Deep Interactome Learning For Generative Drug Design

Protein crystallography data

The structure of Deep Interactome Learning For Generative Drug Design, PDB code: 8pbo was solved by M.Hakansson, D.Focht, K.Atz, G.Schneider, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 44.28 / 1.85
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 93.413, 60.611, 117.945, 90, 102.86, 90
R / Rfree (%) 17.1 / 21.3

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Deep Interactome Learning For Generative Drug Design (pdb code 8pbo). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Deep Interactome Learning For Generative Drug Design, PDB code: 8pbo:
Jump to Fluorine binding site number: 1; 2;

Fluorine binding site 1 out of 2 in 8pbo

Go back to Fluorine Binding Sites List in 8pbo
Fluorine binding site 1 out of 2 in the Deep Interactome Learning For Generative Drug Design


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Deep Interactome Learning For Generative Drug Design within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F501

b:55.0
occ:1.00
F1 A:Y5I501 0.0 55.0 1.0
C18 A:Y5I501 1.4 42.2 1.0
C14 A:Y5I501 2.3 39.0 1.0
C19 A:Y5I501 2.4 45.5 1.0
H14 A:Y5I501 2.4 42.3 1.0
HE1 A:HIS449 2.5 37.5 1.0
H18 A:Y5I501 2.5 46.1 1.0
C15 A:Y5I501 2.8 42.6 1.0
HE2 A:LYS367 2.9 34.8 1.0
HD2 A:PHE363 2.9 47.5 1.0
CE1 A:HIS449 3.1 37.0 1.0
HE2 A:PHE363 3.2 47.2 1.0
HH A:TYR327 3.3 32.6 0.0
H17 A:Y5I501 3.4 44.0 1.0
C13 A:Y5I501 3.6 43.1 1.0
C11 A:Y5I501 3.6 51.0 1.0
ND1 A:HIS449 3.6 36.5 1.0
H15 A:Y5I501 3.6 41.8 1.0
HE1 A:TYR327 3.6 33.0 1.0
HD1 A:HIS449 3.6 30.2 0.0
CD2 A:PHE363 3.7 50.5 1.0
C16 A:Y5I501 3.7 44.1 1.0
CE A:LYS367 3.7 34.6 1.0
HB3 A:CYS285 3.8 35.4 1.0
HZ3 A:LYS367 3.8 38.1 1.0
CE2 A:PHE363 3.8 49.2 1.0
O A:HOH669 3.8 50.7 1.0
HE3 A:LYS367 3.9 34.6 1.0
NE2 A:HIS449 4.0 40.0 1.0
C12 A:Y5I501 4.1 47.2 1.0
NZ A:LYS367 4.1 39.3 1.0
OH A:TYR327 4.1 37.5 1.0
HG A:CYS285 4.1 33.5 0.0
HZ1 A:LYS367 4.2 38.2 1.0
H16 A:Y5I501 4.2 43.5 1.0
HE2 A:HIS449 4.2 33.4 0.0
HB2 A:CYS285 4.3 36.2 1.0
H13 A:Y5I501 4.3 43.0 1.0
CB A:CYS285 4.4 35.3 1.0
CE1 A:TYR327 4.4 31.8 1.0
SD A:MET364 4.6 48.8 1.0
HG2 A:LYS367 4.6 31.4 1.0
O2 A:Y5I501 4.7 47.6 1.0
CG A:HIS449 4.7 35.8 1.0
CZ A:TYR327 4.8 37.1 1.0
HE1 A:PHE282 4.8 44.6 1.0
O A:PHE363 4.8 37.4 1.0
HB2 A:PHE363 4.9 38.3 1.0
C17 A:Y5I501 4.9 43.1 1.0
O A:HOH605 4.9 52.9 1.0
CD A:LYS367 4.9 31.7 1.0
CD2 A:HIS449 4.9 38.3 1.0
CG A:PHE363 4.9 42.5 1.0
SG A:CYS285 5.0 39.4 1.0

Fluorine binding site 2 out of 2 in 8pbo

Go back to Fluorine Binding Sites List in 8pbo
Fluorine binding site 2 out of 2 in the Deep Interactome Learning For Generative Drug Design


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Deep Interactome Learning For Generative Drug Design within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F501

b:65.7
occ:1.00
F2 A:Y5I501 0.0 65.7 1.0
C20 A:Y5I501 1.4 48.8 1.0
C21 A:Y5I501 2.3 52.5 1.0
C7 A:Y5I501 2.4 42.0 1.0
H19 A:Y5I501 2.5 50.6 1.0
O1 A:Y5I501 2.7 45.2 1.0
O A:HOH691 2.9 47.5 1.0
HB2 A:ARG288 3.0 44.2 1.0
HA A:CYS285 3.1 35.2 1.0
HB3 A:ARG288 3.3 43.8 1.0
O A:GLY284 3.3 37.2 1.0
C A:GLY284 3.6 45.6 1.0
CB A:ARG288 3.6 42.2 1.0
O A:HOH654 3.6 61.9 1.0
C4 A:Y5I501 3.6 46.6 1.0
C6 A:Y5I501 3.6 48.9 1.0
H11 A:Y5I501 3.6 46.9 1.0
HG2 A:ARG288 3.7 53.7 1.0
N A:CYS285 3.8 37.4 1.0
CA A:CYS285 3.9 34.1 1.0
C5 A:Y5I501 4.1 44.5 1.0
C8 A:Y5I501 4.1 42.7 1.0
CG A:ARG288 4.2 55.3 1.0
HA3 A:GLY284 4.2 43.1 1.0
HB A:ILE341 4.2 36.1 1.0
H A:ARG288 4.3 38.3 1.0
HD2 A:ARG288 4.4 66.5 1.0
H A:CYS285 4.4 38.8 1.0
H5 A:Y5I501 4.4 46.0 1.0
HG22 A:ILE341 4.4 37.2 1.0
CA A:GLY284 4.4 43.3 1.0
C10 A:Y5I501 4.5 47.4 1.0
SG A:CYS285 4.5 39.4 1.0
H7 A:Y5I501 4.5 43.8 1.0
H6 A:Y5I501 4.6 43.9 1.0
H9 A:Y5I501 4.6 44.2 1.0
C9 A:Y5I501 4.7 44.0 1.0
H A:SER342 4.7 38.1 1.0
HG23 A:ILE341 4.7 38.0 1.0
O A:HOH651 4.7 45.0 1.0
HA2 A:GLY284 4.8 43.4 1.0
C3 A:Y5I501 4.8 58.8 1.0
H10 A:Y5I501 4.8 46.3 1.0
CB A:CYS285 4.8 35.3 1.0
CA A:ARG288 4.9 38.2 1.0
CD A:ARG288 4.9 66.2 1.0
C A:CYS285 4.9 38.4 1.0
CG2 A:ILE341 4.9 38.7 1.0
N A:ARG288 4.9 36.4 1.0
HG3 A:ARG288 5.0 53.5 1.0

Reference:

K.Atz, L.Cotos, C.Isert, M.Hakansson, D.Focht, M.Hilleke, D.F.Nippa, M.Iff, J.Ledergerber, C.C.G.Schiebroek, V.Romeo, J.A.Hiss, D.Merk, P.Schneider, B.Kuhn, U.Grether, G.Schneider. Prospective De Novo Drug Design with Deep Interactome Learning. Nat Commun V. 15 3408 2024.
ISSN: ESSN 2041-1723
PubMed: 38649351
DOI: 10.1038/S41467-024-47613-W
Page generated: Fri Aug 2 21:57:42 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy